These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6288861)

  • 41. Inhibition of sleep and benzodiazepine receptor binding by a beta-carboline derivative.
    Martin JV; Cook JM; Hagen TJ; Mendelson WB
    Pharmacol Biochem Behav; 1989 Sep; 34(1):37-42. PubMed ID: 2560549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of barbiturates with benzodiazepine receptors in the central nervous system.
    Skolnick P; Rice KC; Barker JL; Paul SM
    Brain Res; 1982 Feb; 233(1):143-56. PubMed ID: 6277423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of GABA on peripheral and central type benzodiazepine binding sites in brain.
    Patel J; Marangos PJ
    Neurosci Lett; 1982 May; 30(2):157-60. PubMed ID: 6287365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the kinetics of [3H]diazepam and [3H]flunitrazepam binding to cortical synaptosomal membranes.
    Chiu TH; Rosenberg HC
    J Neurochem; 1982 Dec; 39(6):1716-25. PubMed ID: 6128377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic RO 15-1788 treatment increases the number of benzodiazepine receptors in rat cerebral cortex and hippocampus.
    Medina JH; Novas ML; De Robertis E
    Eur J Pharmacol; 1983 May; 90(1):125-8. PubMed ID: 6307717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain.
    Gee KW; Ehlert FJ; Yamamura HI
    J Pharmacol Exp Ther; 1983 Apr; 225(1):132-7. PubMed ID: 6300371
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition of benzodiazepine and GABA receptor binding by amino-gamma-carbolines and other amino acid pyrolysate mutagens.
    Muraki T; Yamazoe Y; Kato R
    Eur J Pharmacol; 1984 Feb; 98(1):35-44. PubMed ID: 6325210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural features controlling the binding of beta-carbolines to the benzodiazepine receptor.
    Ferretti V; Gilli P; Borea PA
    Acta Crystallogr B; 2004 Aug; 60(Pt 4):481-9. PubMed ID: 15258407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes.
    Müller WE; Schläfer U; Wollert U
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):23-6. PubMed ID: 723967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential sensitivity of "central" and "peripheral" type benzodiazepine receptors to phospholipase A2.
    Havoundjian H; Cohen RM; Paul SM; Skolnick P
    J Neurochem; 1986 Mar; 46(3):804-11. PubMed ID: 3005493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrasting effects of ethyl beta-carboline-3-carboxylate (beta CCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blocker.
    Koe BK; Lebel LA
    Eur J Pharmacol; 1983 May; 90(1):97-102. PubMed ID: 6307723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional heterogeneity of benzodiazepine binding sites in rat brain.
    Stapleton SR; Prestwich SA; Horton RW
    Eur J Pharmacol; 1982 Oct; 84(3-4):221-4. PubMed ID: 6293849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. n-[3H]butyl-beta-carboline-3-carboxylate, a putative endogenous ligand, binds preferentially to subtype 1 of central benzodiazepine receptors.
    Medina JH; de Stein ML; De Robertis E
    J Neurochem; 1989 Mar; 52(3):665-70. PubMed ID: 2537375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of convulsive ligands with benzodiazepine receptors.
    Braestrup C; Schmiechen R; Neef G; Nielsen M; Petersen EN
    Science; 1982 Jun; 216(4551):1241-3. PubMed ID: 6281892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneity of gamma-aminobutyric acid/benzodiazepine/beta-carboline receptor complex in rat spinal cord.
    Santi MR; Cox DH; Guidotti A
    J Neurochem; 1988 Apr; 50(4):1080-6. PubMed ID: 2831297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strain differences in susceptibility to the convulsant actions of 3-carbomethoxy-beta-carboline.
    Schweri MM; Paul SM; Skolnick P
    Pharmacol Biochem Behav; 1983 Dec; 19(6):951-5. PubMed ID: 6657728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of beta-carbolines and caffeine on benzodiazepine receptors: correlations to convulsions and tremor.
    Saano V; Airaksinen MM
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):300-8. PubMed ID: 6295064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of gamma-aminobutyric acid stimulated [3H]diazepam binding by benzodiazepine receptors ligands.
    Marangos PJ; Paul SM; Parma AM; Skolnick P
    Biochem Pharmacol; 1981 Aug; 30(15):2171-4. PubMed ID: 6271134
    [No Abstract]   [Full Text] [Related]  

  • 59. Pre- versus postsynaptic localization of benzodiazepine and beta-carboline binding sites.
    Tietz EI; Chiu TH; Rosenberg HC
    J Neurochem; 1985 May; 44(5):1524-34. PubMed ID: 2985753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of acute administration of diazepam on the binding of [3H]-diazepam and [3H]-gaba to rat cortical membranes.
    Coupet J; Rauh CE; Lippa AS; Beer B
    Pharmacol Biochem Behav; 1981 Dec; 15(6):965-8. PubMed ID: 6275420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.